Jyong Biotech Ltd
MENS64.420USD
+9.290+16.85%
Fechamento 09/11, 16:00（ET）Cotações atrasadas em 15 min
4.90BValor de mercado
--P/L TTM
Mais detalhes de Jyong Biotech Ltd Empresa
Jyong Biotech Ltd is a Taiwan-based science-driven biotechnology company. The Company is mainly engaged in developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the United States (U.S.), the European Union (EU), and Asia. The Company has been developing a series of botanical drug candidates, including primary botanical drug candidate of MCS-2, another clinical-stage botanical drug candidate of PCP, and other preclinical-stage botanical drug candidates. MCS-2 is a new botanical drug candidate developed for treatment of benign prostate hyperplasia/lower urinary tract symptoms (BPH/LUTS). PCP is a new botanical drug candidate developed for the prevention of prostate cancer.
Informações da empresa
Código da empresaMENS
Nome da EmpresaJyong Biotech Ltd
Data de listagemJun 17, 2025
CEOMr. Fu Feng Kuo
Número de funcionários29
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 17
Endereço23F-3, No.95, Section 1, Xintai 5th, Xizhi District
CidadeNEW TAIPEI
Bolsa de valoresNASDAQ Global Market Consolidated
PaísTaiwan
Código postal221
Telefone886227325205
Sitehttps://jyongbio.com/
Código da empresaMENS
Data de listagemJun 17, 2025
CEOMr. Fu Feng Kuo
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Alfred Ying
Mr. Alfred Ying
Chief Financial Officer
Chief Financial Officer
4.00K
--
Fenglin Hsu
Fenglin Hsu
Director and Chief Technology Officer
Director and Chief Technology Officer
3.00K
--
Mr. Hung-Shu Fan
Mr. Hung-Shu Fan
Independent Director
Independent Director
--
--
Ms. Fu-Feng Kuo
Ms. Fu-Feng Kuo
Chairwoman of the Board and Chief Executive Officer
Chairwoman of the Board and Chief Executive Officer
--
--
Ming Tsan Hsu
Ming Tsan Hsu
Independent Director
Independent Director
--
--
,
,
Independent Director
Independent Director
--
--
Dr. Wanwen (Angela) Su
Dr. Wanwen (Angela) Su
Chief Scientific Officer
Chief Scientific Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Alfred Ying
Mr. Alfred Ying
Chief Financial Officer
Chief Financial Officer
4.00K
--
Fenglin Hsu
Fenglin Hsu
Director and Chief Technology Officer
Director and Chief Technology Officer
3.00K
--
Mr. Hung-Shu Fan
Mr. Hung-Shu Fan
Independent Director
Independent Director
--
--
Ms. Fu-Feng Kuo
Ms. Fu-Feng Kuo
Chairwoman of the Board and Chief Executive Officer
Chairwoman of the Board and Chief Executive Officer
--
--
Ming Tsan Hsu
Ming Tsan Hsu
Independent Director
Independent Director
--
--
,
,
Independent Director
Independent Director
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: qua, 3 de set
Atualizado em: qua, 3 de set
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Perfect Minds Co Ltd
33.34%
Laxton Investments Company Ltd
10.04%
Linkage Gladden Enterprise Ltd
9.03%
Peak Valley International Co., Ltd.
6.71%
Honest Dynasty Ltd
3.08%
Outro
37.80%
Investidores
Investidores
Proporção
Perfect Minds Co Ltd
33.34%
Laxton Investments Company Ltd
10.04%
Linkage Gladden Enterprise Ltd
9.03%
Peak Valley International Co., Ltd.
6.71%
Honest Dynasty Ltd
3.08%
Outro
37.80%
Tipos de investidores
Investidores
Proporção
Corporation
62.20%
Hedge Fund
0.09%
Investment Advisor
0.03%
Investment Advisor/Hedge Fund
0.01%
Outro
37.67%
Participação acionária institucional
Atualizado em: qua, 2 de jul
Atualizado em: qua, 2 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
7
47.29M
62.20%
+47.29M
2025Q2
7
47.29M
62.20%
+47.29M
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Perfect Minds Co Ltd
25.35M
33.34%
+25.35M
--
Jun 17, 2025
Laxton Investments Company Ltd
7.63M
10.04%
+7.63M
--
Jun 17, 2025
Linkage Gladden Enterprise Ltd
6.86M
9.03%
+6.86M
--
Jun 17, 2025
Peak Valley International Co., Ltd.
5.10M
6.71%
+5.10M
--
Jun 17, 2025
Honest Dynasty Ltd
2.34M
3.08%
+2.34M
--
Jun 17, 2025
Ying (Alfred)
4.00K
0.01%
+4.00K
--
Jun 17, 2025
Hsu (Fenglin)
3.00K
0%
+3.00K
--
Jun 17, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
